The global veterinary API market size is calculated at USD 5.62 billion in 2025 and is forecasted to reach around USD 8.83 billion by 2034, accelerating at a CAGR of 5.14% from 2025 to 2034. The North America market size surpassed USD 1.93 billion in 2024 and is expanding at a CAGR of 5.25% during the forecast period. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Veterinary API Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Veterinary API Market Revenue and Volume Forecast, by Service Type
8.1.1. In-House Manufacturing
8.1.1.1. Market Revenue and Volume Forecast
8.1.2. Contract Outsourcing
8.1.2.1. Market Revenue and Volume Forecast
9.1. Veterinary API Market Revenue and Volume Forecast, by Synthesis Type
9.1.1. Chemical-based API
9.1.1.1. Market Revenue and Volume Forecast
9.1.2. Biological API
9.1.2.1. Market Revenue and Volume Forecast
9.1.3. HPAPI
9.1.3.1. Market Revenue and Volume Forecast
10.1. Veterinary API Market Revenue and Volume Forecast, by Animal Type
10.1.1. Production Animals
10.1.1.1. Market Revenue and Volume Forecast
10.1.2. Companion Animals
10.1.2.1. Market Revenue and Volume Forecast
11.1. Veterinary API Market Revenue and Volume Forecast, by Therapeutic
11.1.1. Antiparasitics
11.1.1.1. Market Revenue and Volume Forecast
11.1.2. Anti-infectives
11.1.2.1. Market Revenue and Volume Forecast
11.1.3. NSAIDs
11.1.3.1. Market Revenue and Volume Forecast
11.1.4. Others
11.1.4.1. Market Revenue and Volume Forecast
12.1. North America
12.1.1. Market Revenue and Volume Forecast, by Service Type
12.1.2. Market Revenue and Volume Forecast, by Synthesis Type
12.1.3. Market Revenue and Volume Forecast, by Animal Type
12.1.4. Market Revenue and Volume Forecast, by Therapeutic
12.1.5. U.S.
12.1.5.1. Market Revenue and Volume Forecast, by Service Type
12.1.5.2. Market Revenue and Volume Forecast, by Synthesis Type
12.1.5.3. Market Revenue and Volume Forecast, by Animal Type
12.1.5.4. Market Revenue and Volume Forecast, by Therapeutic
12.1.6. Rest of North America
12.1.6.1. Market Revenue and Volume Forecast, by Service Type
12.1.6.2. Market Revenue and Volume Forecast, by Synthesis Type
12.1.6.3. Market Revenue and Volume Forecast, by Animal Type
12.1.6.4. Market Revenue and Volume Forecast, by Therapeutic
12.2. Europe
12.2.1. Market Revenue and Volume Forecast, by Service Type
12.2.2. Market Revenue and Volume Forecast, by Synthesis Type
12.2.3. Market Revenue and Volume Forecast, by Animal Type
12.2.4. Market Revenue and Volume Forecast, by Therapeutic
12.2.5. UK
12.2.5.1. Market Revenue and Volume Forecast, by Service Type
12.2.5.2. Market Revenue and Volume Forecast, by Synthesis Type
12.2.5.3. Market Revenue and Volume Forecast, by Animal Type
12.2.5.4. Market Revenue and Volume Forecast, by Therapeutic
12.2.6. Germany
12.2.6.1. Market Revenue and Volume Forecast, by Service Type
12.2.6.2. Market Revenue and Volume Forecast, by Synthesis Type
12.2.6.3. Market Revenue and Volume Forecast, by Animal Type
12.2.6.4. Market Revenue and Volume Forecast, by Therapeutic
12.2.7. France
12.2.7.1. Market Revenue and Volume Forecast, by Service Type
12.2.7.2. Market Revenue and Volume Forecast, by Synthesis Type
12.2.7.3. Market Revenue and Volume Forecast, by Animal Type
12.2.7.4. Market Revenue and Volume Forecast, by Therapeutic
12.2.8. Rest of Europe
12.2.8.1. Market Revenue and Volume Forecast, by Service Type
12.2.8.2. Market Revenue and Volume Forecast, by Synthesis Type
12.2.8.3. Market Revenue and Volume Forecast, by Animal Type
12.2.8.4. Market Revenue and Volume Forecast, by Therapeutic
12.3. APAC
12.3.1. Market Revenue and Volume Forecast, by Service Type
12.3.2. Market Revenue and Volume Forecast, by Synthesis Type
12.3.3. Market Revenue and Volume Forecast, by Animal Type
12.3.4. Market Revenue and Volume Forecast, by Therapeutic
12.3.5. India
12.3.5.1. Market Revenue and Volume Forecast, by Service Type
12.3.5.2. Market Revenue and Volume Forecast, by Synthesis Type
12.3.5.3. Market Revenue and Volume Forecast, by Animal Type
12.3.5.4. Market Revenue and Volume Forecast, by Therapeutic
12.3.6. China
12.3.6.1. Market Revenue and Volume Forecast, by Service Type
12.3.6.2. Market Revenue and Volume Forecast, by Synthesis Type
12.3.6.3. Market Revenue and Volume Forecast, by Animal Type
12.3.6.4. Market Revenue and Volume Forecast, by Therapeutic
12.3.7. Japan
12.3.7.1. Market Revenue and Volume Forecast, by Service Type
12.3.7.2. Market Revenue and Volume Forecast, by Synthesis Type
12.3.7.3. Market Revenue and Volume Forecast, by Animal Type
12.3.7.4. Market Revenue and Volume Forecast, by Therapeutic
12.3.8. Rest of APAC
12.3.8.1. Market Revenue and Volume Forecast, by Service Type
12.3.8.2. Market Revenue and Volume Forecast, by Synthesis Type
12.3.8.3. Market Revenue and Volume Forecast, by Animal Type
12.3.8.4. Market Revenue and Volume Forecast, by Therapeutic
12.4. MEA
12.4.1. Market Revenue and Volume Forecast, by Service Type
12.4.2. Market Revenue and Volume Forecast, by Synthesis Type
12.4.3. Market Revenue and Volume Forecast, by Animal Type
12.4.4. Market Revenue and Volume Forecast, by Therapeutic
12.4.5. GCC
12.4.5.1. Market Revenue and Volume Forecast, by Service Type
12.4.5.2. Market Revenue and Volume Forecast, by Synthesis Type
12.4.5.3. Market Revenue and Volume Forecast, by Animal Type
12.4.5.4. Market Revenue and Volume Forecast, by Therapeutic
12.4.6. North Africa
12.4.6.1. Market Revenue and Volume Forecast, by Service Type
12.4.6.2. Market Revenue and Volume Forecast, by Synthesis Type
12.4.6.3. Market Revenue and Volume Forecast, by Animal Type
12.4.6.4. Market Revenue and Volume Forecast, by Therapeutic
12.4.7. South Africa
12.4.7.1. Market Revenue and Volume Forecast, by Service Type
12.4.7.2. Market Revenue and Volume Forecast, by Synthesis Type
12.4.7.3. Market Revenue and Volume Forecast, by Animal Type
12.4.7.4. Market Revenue and Volume Forecast, by Therapeutic
12.4.8. Rest of MEA
12.4.8.1. Market Revenue and Volume Forecast, by Service Type
12.4.8.2. Market Revenue and Volume Forecast, by Synthesis Type
12.4.8.3. Market Revenue and Volume Forecast, by Animal Type
12.4.8.4. Market Revenue and Volume Forecast, by Therapeutic
12.5. Latin America
12.5.1. Market Revenue and Volume Forecast, by Service Type
12.5.2. Market Revenue and Volume Forecast, by Synthesis Type
12.5.3. Market Revenue and Volume Forecast, by Animal Type
12.5.4. Market Revenue and Volume Forecast, by Therapeutic
12.5.5. Brazil
12.5.5.1. Market Revenue and Volume Forecast, by Service Type
12.5.5.2. Market Revenue and Volume Forecast, by Synthesis Type
12.5.5.3. Market Revenue and Volume Forecast, by Animal Type
12.5.5.4. Market Revenue and Volume Forecast, by Therapeutic
12.5.6. Rest of LATAM
12.5.6.1. Market Revenue and Volume Forecast, by Service Type
12.5.6.2. Market Revenue and Volume Forecast, by Synthesis Type
12.5.6.3. Market Revenue and Volume Forecast, by Animal Type
12.5.6.4. Market Revenue and Volume Forecast, by Therapeutic
13.1. Merck Animal Health
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. Boehringer Ingelheim Animal Health
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. Elanco Animal Health, Bayer Animal Health
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. Alivira Animal Health Ltd.
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. Chempro Pharma Pvt. Ltd.
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. Elanco
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. Excel Industries Ltd.
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
13.8. MENADIONA
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial Performance
13.8.4. Recent Initiatives
13.9. Ofichem Group
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial Performance
13.9.4. Recent Initiatives
13.10. Qilu Animal Health Products Co., Ltd.
13.10.1. Company Overview
13.10.2. Product Offerings
13.10.3. Financial Performance
13.10.4. Recent Initiatives
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
15.1. About Us
15.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
Plan your call and get expert insights!
Schedule a Meeting
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Get a Sample
Report Description
Get a Sample
Report Description